Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Should You Take Comfort From Insider Transactions At Japara Healthcare Limited (ASX:JHC)?

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On the other hand, we'd be remiss not to mention that insider sales have been known to precede tough periods for a business. So before you buy or sell Japara Healthcare Limited (ASX:JHC), you may well want to know whether insiders have been buying or selling.

What Is Insider Selling?

Most investors know that it is quite permissible for company leaders, such as directors of the board, to buy and sell stock in the company. However, rules govern insider transactions, and certain disclosures are required.

Insider transactions are not the most important thing when it comes to long-term investing. But logic dictates you should pay some attention to whether insiders are buying or selling shares. As Peter Lynch said, 'insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Check out our latest analysis for Japara Healthcare

Japara Healthcare Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider purchase was by Independent Non-Executive Director Leanne Rowe for AU$127k worth of shares, at about AU$1.11 per share. That implies that an insider found the current price of AU$1.17 per share to be enticing. Of course they may have changed their mind. But this suggests they are optimistic. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. The good news for Japara Healthcare share holders is that insiders were buying at near the current price.

While Japara Healthcare insiders bought shares last year, they didn't sell. The chart below shows insider transactions (by individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

ASX:JHC Recent Insider Trading, September 27th 2019
ASX:JHC Recent Insider Trading, September 27th 2019

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Japara Healthcare Insiders Bought Stock Recently

Over the last quarter, Japara Healthcare insiders have spent a meaningful amount on shares. Not only was there no selling that we can see, but they collectively bought AU$142k worth of shares. This could be interpreted as suggesting a positive outlook.

Insider Ownership

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. It appears that Japara Healthcare insiders own 9.1% of the company, worth about AU$29m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.